21:09:25 Europe / Stockholm

Kalender

2024-10-31 Kvartalsrapport 2024-Q3
2024-08-29 Kvartalsrapport 2024-Q2
2024-04-30 Ordinarie utdelning GENT 0.00 NOK
2024-04-30 Kvartalsrapport 2024-Q1
2024-04-29 Årsstämma 2024
2024-02-09 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-05 Kvartalsrapport 2023-Q1
2023-05-05 Ordinarie utdelning GENT 0.00 NOK
2023-05-04 Årsstämma 2023
2023-02-16 Bokslutskommuniké 2022
2022-10-27 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-19 Ordinarie utdelning GENT 0.00 NOK
2022-05-18 Årsstämma 2022
2022-04-28 Kvartalsrapport 2022-Q1
2022-02-17 Bokslutskommuniké 2021
2021-10-21 Kvartalsrapport 2021-Q3
2021-08-25 Kvartalsrapport 2021-Q2
2021-05-05 Ordinarie utdelning GENT 0.00 NOK
2021-05-04 Årsstämma 2021
2021-04-16 Kvartalsrapport 2021-Q1
2021-02-11 Bokslutskommuniké 2020
2020-10-29 Kvartalsrapport 2020-Q3
2020-08-21 Kvartalsrapport 2020-Q2
2020-05-15 Ordinarie utdelning GENT 0.00 NOK
2020-05-14 Årsstämma 2020
2020-04-24 Kvartalsrapport 2020-Q1
2020-02-14 Bokslutskommuniké 2019
2019-11-21 Extra Bolagsstämma 2019
2019-05-10 Ordinarie utdelning GENT 0.00 NOK
2018-07-13 Extra Bolagsstämma 2018
2018-06-13 Ordinarie utdelning GENT 0.00 NOK
2018-02-27 Bokslutskommuniké 2017
2017-06-06 Årsstämma 2017

Beskrivning

LandNorge
ListaOB Match
SektorHälsovård
IndustriBioteknik
Gentian Diagnostics är ett norskt bolag som utvecklar olika produkter inom hälsovård. Exempel är diagnostiska test med målet att utveckla och effektivisera diagnostisk behandling, vilket innefattar behandling utav cancer och hjärt- och kärlsjukdomar. En stor del av verksamheten innefattar FoU utveckling. Bolaget grundades 1998 och har sitt huvudkontor i Moss, Norge.
Filter arrow-icon
År arrow-icon
Typ arrow-icon
Språk arrow-icon
2024-02-09 08:00:00 GENT: Fourth quarter and full year 2023 report
2024-01-30 14:04:07 GENT: Invitation to presentation of fourth quarter results
2023-12-19 14:13:36 GENT: Disclosure of shareholding
2023-12-18 09:23:37 GENT: Resignation of board member
2023-12-11 13:29:01 GENT: Financial calendar
2023-11-24 10:07:59 GENT: Mandatory notification of trade
2023-10-26 08:00:00 GENT: Third quarter 2023 report
2023-10-18 12:19:14 GENT: Invitation to presentation of third quarter results
2023-08-29 13:55:29 GENT: Mandatory notification of trade
2023-08-24 08:00:00 GENT: Second quarter 2023 report
2023-08-16 09:34:48 GENT: Invitation to presentation of second quarter results
2023-06-15 08:38:12 GENT: Gentian acquires Getica for SEK 3.0 million
2023-05-10 10:42:30 GENT: Capital Markets Day at 12.30 CEST today
2023-05-08 14:41:19 Reminder: Invitation to Capital Markets Day 10 May 2023
2023-05-05 17:25:36 Disclosure of shareholdings - Holta Invest AS
2023-05-05 17:05:46 GENT: Mandatory notification of trade
2023-05-05 07:30:00 GENT: First quarter 2023 report
2023-05-04 11:18:21 GENT: Minutes from Annual General Meeting
2023-04-27 10:55:58 GENT: Invitation to presentation of first quarter results
2023-04-14 09:24:39 GENT: Gentian Diagnostics invites to Capital Markets Day
2023-04-12 13:12:08 GENT: Notice of annual general meeting
2023-03-30 16:48:43 GENT: Annual report 2022
2023-03-17 15:45:15 GENT: Financial calendar
2023-02-16 08:00:00 GENT: Fourth quarter and full year 2022 report
2023-02-10 13:42:57 GENT: Invitation to presentation of fourth quarter results
2022-12-15 12:50:41 GENT: Mandatory notification of trade
2022-12-14 15:24:42 GENT: Gentian Diagnostics appoints new CSO
2022-12-13 10:03:29 GENT: Financial calendar
2022-12-05 11:09:10 GENT: Patent granted for NT-proBNP in the U.S.
2022-10-27 08:15:23 GENT: Third quarter 2022 report
2022-10-27 08:00:00 GENT: Third quarter 2023 report
2022-10-21 10:41:55 GENT: Invitation to presentation of third quarter results
2022-09-28 11:00:31 GENT: Gentian Diagnostics obtains IVDR certification
2022-08-29 15:57:56 GENT: Mandatory notification of trade
2022-08-26 13:17:37 GENT: Mandatory notification of trade
2022-08-25 16:28:17 GENT: Mandatory notification of trade
2022-08-25 08:00:00 GENT: Second quarter 2022 report
2022-08-18 12:41:33 GENT: Invitation to presentation of second quarter results
2022-05-18 12:22:11 GENT: Minutes of annual general meeting